Spanning 360,000 ft², the new facility will manufacture the autoinjectors used in medications in various therapeutic areas. Credit: SHL Medical.
Swiss-based SHL Medical has opened a new autoinjector manufacturing facility in North Charleston, South Carolina, US, with a $220m investment.
This 360,000ft² site will help the company meet the increasing global demand for autoinjectors, particularly in the cardiometabolic sector.
The facility will manufacture the autoinjectors used in medications in various therapeutic areas, including endocrine and metabolic disorders, musculoskeletal diseases, and dermatology.
SHL Medical noted that the North Charleston site is poised to offer efficiency, precision, and quality drug delivery solutions, with its medical device injection moulding technology and fully automated assembly capabilities.
The new facility has generated more than 300 local employment opportunities.
It utilises the current final assembly, labelling, and packaging operations in Deerfield Beach, Florida, and benefits from the integration of recent acquisitions under the company’s sub-group SHL Advantec, which offers automation and tooling solutions for the healthcare sector.
SHL Medical stated that it is on track to deliver 1.5 billion devices to customers this year.
SHL Medical chairman and CEO Ulrich Faessler said: “US-based production is a major step forward in our global expansion and reinforces our position as the leader in providing end-to-end drug delivery solutions.
“With our established site in Taiwan and the upcoming facility in Switzerland, we will be the only autoinjector manufacturer operating across three continents, bringing us even closer to our customers.”
With more than 5,000 employees across Switzerland, Sweden, Taiwan, and the US, SHL Medical claims to leverage its in-house manufacturing offerings to deliver end-to-end services.
In June 2025, Aptar Digital Health partnered with SHL Medical to improve the patient experience in [injectable therapies by integrating digital health solutions](https://www.medicaldevice-network.com/news/aptar-shl-drug-delivery/) with drug delivery systems.